SAN ANTONIO – The South Texas Blood & Tissue Center (STBTC) has provided more than 200 units of blood to hospitals in South Texas treating Sunday’s shooting victims in Sutherland Springs.
STBTC, a subsidiary of nonprofit BioBridge Global, provided blood to Connally Memorial Medical Center in Floresville, the San Antonio Military Medical Center trauma center and University Hospital, where victims were being treated. The center is continuing to provide blood to these hospitals and more than 70 hospitals across the region.
“After a tragedy like this, people want to know what they can do to help. A concrete way to help is to donate blood to help replenish blood supplies so we’re ready to help the next patients who need blood, said Elizabeth Waltman, chief operating officer of the South Texas Blood & Tissue Center.
It is critical that a constant supply of blood is available for hospitals at all times – especially before tragedies occur. It can take up to 24 hours to test and process blood before it’s ready for transfusion. STBTC has to be prepared for the next need, no matter where it occurs.
Anyone with O-positive or O-negative blood is asked to donate, as supplies are low.
STBTC also is asking for community members to donate platelets. Platelets are the blood components that help promote clotting, and they are constantly in demand.
People can donate at any of the seven South Texas Blood & Tissue Center donor rooms or at mobile blood drives happening around South Texas today. They also can donate at SAMMC and at University Hospital. In addition, STBTC is arranging blood drives this week in the Floresville area and across South Texas.
Members of the community can schedule a blood donation by going to SouthTexasBlood.org or calling 210-731-5590. Information also is available on our Facebook page at Connect For Life.
The need for blood donations will remain high especially in the coming months, so donors are asked to remember to give as often as possible. STBTC serves more than 70 hospitals and clinics, including University Hospital.
All donors will need to have a photo ID. Anyone who is 16 years old and weighs at least 120 pounds (with parental consent form), or 17 years old and weighs at least 110 pounds and is in good general health may donate blood.
BCW and Abbott Laboratories’ collaboration will help to advance personalized medicine by better identifying patients that could benefit from new FDA approved medication
MILWAUKEE, Aug. 29, 2017 /PRNewswire-USNewswire/ — BloodCenter of Wisconsin’s Diagnostic Laboratories, part of Versiti, is the first to offer testing using Abbott Laboratories’ RealTime IDH2 assay that identifies specific gene mutations in patients with acute myeloid leukemia (AML). BloodCenter’s breakthrough offering, which follows Abbott’s recent approval from the U.S. Food and Drug Administration, helps to deliver new and more effective treatments to patients with relapsed and refractory AML.
BloodCenter’s test, IDH2 Abbott RealTime PCR, is more sensitive to detecting the IDH2 genetic mutation found in patients’ blood and bone marrow samples. The method detects single nucleotide variants (SNVs) coding nine IDH2 R140 and R172 mutations in patients’ DNA. With a five-day turnaround time, this test helps identify AML patients that could benefit from new treatments, including the recently FDA approved drug called IDHIFA®.
According to the National Cancer Institute, more than 21,000 people will be diagnosed with AML this year and more than 10,000 patients will die due to the disease. Between 8 percent and 19 percent of AML patients have IDH2 mutations.
“This new test is an exciting addition to BloodCenter’s molecular oncology diagnostics portfolio. Through our collaboration with Abbott, we can continue to help provide better treatment options and outcomes for AML patients,” said Dr. Matthew Anderson, M.D., Ph.D., VP and medical director of the Diagnostic Laboratories at BloodCenter of Wisconsin. “This test will help physicians to provide more customized treatment for patients, and is another example of how BloodCenter is advancing precision medicine in our areas of expertise.”
About BloodCenter of Wisconsin
BloodCenter of Wisconsin, part of Versiti, is a not-for-profit organization headquartered in Milwaukee, Wis., that specializes in blood services, esoteric diagnostic testing, organ, tissue and stem cell donation, medical services and leading-edge research. We advance patient care by delivering life-saving solutions grounded in unparalleled medical and scientific expertise. The collective efforts of Versiti affiliates result in improved patient outcomes, expanded access to care, and cost efficiencies for healthcare systems nationwide. For more information, visit www.bcw.edu and www.versiti.org .
Contact: Matt Queen
(CINCINNATI – AUGUST 10, 2017) After more than three decades in the field of blood banking, Hoxworth Blood Center Medical Director, Patricia “Chris” Carey, MD, is calling it a career.
Dr. Carey began that career at Hoxworth Blood Center in 1983, serving a one-year fellowship in Transfusion Medicine at the University of Cincinnati College of Medicine and continued to quickly advance, serving in roles such as Associate Medical Director from 1984 – 1990 and her current position as Medical Director, which she assumed in 1997. In addition to her work at Hoxworth Blood Center, Dr. Carey is also an integral member of the College of Medicine faculty. Carey serves as a professor in the Department of Pathology and Laboratory Medicine at the College of Medicine, and Program Director of Fellowship in Transfusion/Blood Banking; as well as Transfusion Service Director at University of Cincinnati Medical Center. Read more click 2017_DrCareyRetirement
(CINCINNATI, April 17, 2017)— Ronald Sacher, MD, director of Hoxworth Blood Center, has been named the 2018 president-elect of the American Clinical and Climatological Association (ACCA). Founded in 1884, the ACCA is the oldest medical society in the United States. ‘Climatological’ refers to the fact that climate was a key factor in the treatment of tuberculosis, a major health problem when the society was formed. Read more >>Sacher ACCA president-elect
HemaTerra Technologies is pleased to announce a new relationship with IT Synergistics to reduce the cost of operations and redundant data entry for our mutual clients. Organizations using HemaTerra’s integrated products – HemaConnect donor recruitment, HemaControl order entry and inventory management, and HemaComply product QC and equipment management – who also use IT Synergistics’ LifeTec Elite / DoVac Elite systems will now have even greater efficiencies in their operations. Read more >>
Milwaukee, Wis., — February 6, 2017 — BloodCenter of Wisconsin, part of Versiti, and Fresenius Kabi, have launched a pilot program at Children’s Hospital of Wisconsin using radio frequency identification technology (RFID) to digitally track blood usage and inventory. Children’s Hospital of Wisconsin is the first pediatric hospital in the country to use RFID in the area of transfusion medicine, the hospital said. Fresenius Kabi is a global health care company that specializes in medicines and technologies for infusion, transfusion and clinical nutrition.
The project involves the use of specialized RFID tags applied to blood bags prior to shipment to hospitals. These tags can be tracked automatically as the blood moves through the hospital, and to the point at which it is used to treat patients. This process allows for real-time information designed to help health care professionals optimize the availability of their blood supply.
The use of RFID allows for the sharing of blood component inventory data easily and quickly between blood centers and hospitals.
“This innovative approach to tracking our hospital’s blood supply will provide visibility to the location, usage and inventory status of our blood products,” said Jason Jarzembowski, MD, PhD, medical director of the Children’s Hospital of Wisconsin laboratory. “We can better manage our blood supply and plan for what is needed – optimizing the use of the life-saving gifts by blood donors.”
The RFID technology electronically tracks the blood from the time it leaves BloodCenter of Wisconsin, to the hospital’s transfusion service area, and on to use of the products. Children’s Hospital and BloodCenter can jointly look at the movement of products to better inform immediate need and inventory status.
“Getting the right blood products to the right patient more efficiently helps to reduce costs, which is a critical priority in health care today,” said Dean Gregory, president, Medical Devices, for Fresenius Kabi in North America. “We call this technology ‘CompoTrace’ and it’s designed specifically to help improve the vital supply chain of care between blood centers, hospitals and patients.”
The CompoTrace pilot program at BloodCenter of Wisconsin and Children’s Hospital began in October 2016 and will conclude in February 2017. Fresenius Kabi is planning similar projects at other hospitals in 2017.
BloodCenter of Wisconsin spearheaded the use of RFID technology in non-pediatric transfusion medicine environments in 2006 under a National Institutes of Health grant.
About BloodCenter of Wisconsin
BloodCenter of Wisconsin, part of Versiti, is a not-for-profit organization that specializes in blood services, organ, tissue and marrow donation, diagnostic testing, medical services and leading-edge research. BloodCenter of Wisconsin is the exclusive provider of blood to hospitals in 30 Wisconsin counties, as well as to hospitals and patients across the country. BloodCenter of Wisconsin advances patient care by delivering life-saving solutions grounded in unparalleled medical and scientific expertise. For more information, visit www.bcw.edu.
Versiti is a strategic affiliation of successful health care organizations whose vision is to improve the health of patients as the national leader in innovative transfusion solutions for health care systems. Working together, Versiti offers hospitals a more comprehensive range of services, including transfusion medicine, transplantation, stem cell and cellular therapies, hematology, oncology and genomics. At Versiti, they are passionate about improving the lives of their patients and hospital partners. Versiti’s expertise and resources lead to new products, solutions and services to meet patient and hospital needs. For more information, visit www.Versiti.org.
About Fresenius Kabi
Fresenius Kabi is a global health care company that specializes in medicine and technologies for infusion, transfusion and clinical nutrition. The company’s product and services are used to help care for critically and chronically ill patients. The company’s U.S. headquarters is in Lake Zurich, Illinois. The company’s global headquarters is in Bad Homburg, Germany. For more information about Fresenius Kabi in the United States, please visit www.fresenius-kabi.u.s.
About Children’s Hospital of Wisconsin
Children’s Hospital of Wisconsin is an independent health care system dedicated solely to the health and well-being of children. The hospital, with locations in Milwaukee and Neenah, Wisconsin, is recognized as one of the leading pediatric health care centers in the United States. It is ranked in all 10 specialty areas in U.S. News & World Report’s 2016-17 Best Children’s Hospitals report. Children’s provides primary care, specialty care, urgent care, emergency care, community health services, foster and adoption services, child and family counseling, child advocacy services and family resource centers.